|
Independent blinded validation of an AI-based digital histology classifier for prostate cancer recurrence and metastasis risk prediction. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
Research Funding - PathomIQ |
Patents, Royalties, Other Intellectual Property - I received royalty distribution from Memorial Sloan Kettering Cancer Center as the inventor of 2 patents. |
|
|
|
Stock and Other Ownership Interests - PathomIQ |
Patents, Royalties, Other Intellectual Property - Patents pending in the area of biomarker discovery using AI on histopathology data for patient outcome prediction. |
|
|
Employment - Abbott Laboratories (I) |
Stock and Other Ownership Interests - PathomIQ |
Travel, Accommodations, Expenses - PathomIQ |
|
|
Stock and Other Ownership Interests - Colby Pharmaceutical; PathomIQ |
Patents, Royalties, Other Intellectual Property - Issued patents: 9,023,837 8,466,130 7,491,849 7,453,011 7,235,695 7,186,825 7,026,347 6,982,351 6,794,545 5,880,161 5,541,230 |
Travel, Accommodations, Expenses - Dhristi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Medarex; EMD Serono; Foundation Medicine; Gilead Sciences; Merck; Natera; Pfizer; Seagen |
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Janssen Oncology; Seagen |
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - PathomiQ; Senex Biotechnology |
Leadership - AIQ Solutions; PathomIQ; Senex Biotechnology |
Stock and Other Ownership Interests - AIQ Solutions; PathomIQ; Senex Biotechnology |
Consulting or Advisory Role - Cullgen; Leidos Biomedical Research |
|
|
No Relationships to Disclose |
|
|
|
|
|
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics |
Research Funding - Gilead Sciences (Inst); PathomIQ (Inst); Varian Medical Systems (Inst) |
Travel, Accommodations, Expenses - Varian Medical Systems |
(OPTIONAL) Uncompensated Relationships - Veracyte |